AED ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
158Tuberous sclerosis1

158. Tuberous sclerosis


Clinical trials : 112 Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03356769
(ClinicalTrials.gov)
November 20, 20172/11/2017Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis ComplexA Placebo-controlled Study of Efficacy & Safety of Aspirin as an add-on Treatment in Patients With Tuberous Sclerosis Complex (TSC) & Refractory SeizuresTuberous Sclerosis Complex;Aspirin;Epilepsy;Cognitive Decline;Skin LesionsDrug: Aspirin;Drug: AED;Drug: PlaceboPeking Union Medical College HospitalShijiazhuang Yiling Pharmaceutical Co. LtdRecruiting6 Years30 YearsAll98Phase 2China